Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9167 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.907 |
High Similarity |
NPD1240 |
Approved |
0.8931 |
High Similarity |
NPD1607 |
Approved |
0.8797 |
High Similarity |
NPD1510 |
Phase 2 |
0.8667 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8618 |
High Similarity |
NPD9493 |
Approved |
0.8603 |
High Similarity |
NPD1549 |
Phase 2 |
0.8593 |
High Similarity |
NPD1551 |
Phase 2 |
0.8583 |
High Similarity |
NPD9717 |
Approved |
0.848 |
Intermediate Similarity |
NPD9545 |
Approved |
0.8478 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8429 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8385 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8369 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8369 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8369 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8369 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8346 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8296 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8276 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8235 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8217 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8188 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8169 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8143 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8085 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8082 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8058 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8056 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8041 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8041 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD2654 |
Approved |
0.8014 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7973 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7973 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7967 |
Intermediate Similarity |
NPD74 |
Approved |
0.7967 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7959 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD411 |
Approved |
0.7933 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD2801 |
Approved |
0.791 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7887 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7886 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7886 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7881 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7877 |
Intermediate Similarity |
NPD920 |
Approved |
0.7867 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7847 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7806 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7744 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD5401 |
Approved |
0.773 |
Intermediate Similarity |
NPD3748 |
Approved |
0.771 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7698 |
Intermediate Similarity |
NPD943 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7681 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7606 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7564 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7562 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7547 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2344 |
Approved |
0.75 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD919 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7445 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7445 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7429 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD5402 |
Approved |
0.74 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7388 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7375 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD6099 |
Approved |
0.731 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7273 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD17 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD520 |
Approved |
0.7252 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD940 |
Approved |
0.72 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD846 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7163 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7111 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7109 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD1201 |
Approved |
0.6975 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6972 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6954 |
Remote Similarity |
NPD2354 |
Approved |
0.6954 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD1470 |
Approved |
0.6943 |
Remote Similarity |
NPD37 |
Approved |
0.6929 |
Remote Similarity |
NPD4749 |
Approved |
0.6923 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6913 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6913 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6913 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6906 |
Remote Similarity |
NPD1281 |
Approved |
0.6903 |
Remote Similarity |
NPD1653 |
Approved |
0.6901 |
Remote Similarity |
NPD4287 |
Approved |
0.6899 |
Remote Similarity |
NPD9697 |
Approved |
0.6897 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6883 |
Remote Similarity |
NPD9509 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD2186 |
Approved |
0.6879 |
Remote Similarity |
NPD196 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD1876 |
Approved |
0.6875 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6875 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6853 |
Remote Similarity |
NPD454 |
Approved |
0.6852 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD1613 |
Approved |
0.6849
|
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |